Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADAPT Study of FTC/TDF PrEP Dosing
NCT01327651Phase 2Completed
- Sponsor
- HIV Prevention Trials Network
- Start
- Aug 2011
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by HIV Prevention Trials Network. Started Aug 2011; status: completed.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01327651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01327651.